Innovation for what really matters

Innovation driven by research your realities

Since 2003, we have been investing in innovation to create bioproduction and antibody discovery tools aligned with your challenges: time savings, cost reduction, and better projection toward clinical success. We develop proprietary technologies to remove operational problems :

• RocketAbs: to cut your immunization timelines in half.

• XtenCHO™ Race: to reduce your production costs with yields up to 2× higher than market standards.

We also integrate AI (Artificial Intelligence) into your research workflows through our AIxplore services.  AI gets you to results with fewer lab experiments – saving time & costs. At ProteoGenix, our IA is built by bioinformaticians to turn AI-generated data into meaningful results. 

Observed results with IA:

• 30% reduction in development time
• 100% success to date on antibody humanization projects

Innovation for your most complex projects

Master scientific and operational complexity, step by step.

Complex targets should not slow down your goals. Continuous innovation means tackling ever more complex challenges and delivering where tohers fall short.

• Complex targets : antibody development against GPCRs, ion channels, and peptide–MHC complexes, supported by native-conformation antigens (e.g. nanodiscs) and VHH generation.
• Next-generation formats: expertise in bispecific projects, ADCs, CAR-T, and fully human antibodies.
• Genetic diversity for phage display: enriched and continuously updated libraries, including a human anti-cancer library (86 patients, 18 cancer types) and access to a naive bank of 368 donors.

Innovation that anticipates downstream constraints.

Avoid late-stage roadblocks by anticipating industrialization, reproducibility, and compliance constraints.

• AI-assisted developability: early assessment of stability and manufacturability to identify and mitigate risks.
• Robustness & scalability: a smooth transition to large-scale development through our three bioproduction platforms.
• Ethics: innovation to minimise animal use in research by offering effective non-animal alternatives including continuously innovated phage display services.

You protect the value of your assets through rigorous anticipation:

• 100% IP-Free & royalty free: for most of our services, maximizing asset value for fundraising or partnerships.
• Documentation: project deliverables provide the data needed to support regulatory compliance